Heparinized Nanohydroxyapatite/Collagen Biocomposite Granules with Immobilized Anti-inflammatory and Antimicrobials for Bone Regeneration

Background and Rationale:

Bone infections such as osteomyelitis and periodontitis represent significant clinical challenges due to their complex pathology involving bacterial infection, inflammation, and tissue necrosis. The primary causative agent of osteomyelitis is Staphylococcus aureus, and current clinical treatment often relies on systemic administration of antibiotics like vancomycin, which, while effective, may not ensure optimal local concentrations and can contribute to systemic side effects.

In parallel, the body's natural inflammatory response following bone injury, while essential for healing, can become excessive, resulting in chronic pain and delayed regeneration. High doses of systemic anti-inflammatory drugs are commonly used, further complicating recovery.

Recent advances have demonstrated the potential of nanohydroxyapatite (nHA)/collagen biocomposites for bone tissue engineering due to their excellent biocompatibility and similarity to native bone. By functionalizing these scaffolds with anti-inflammatory and antimicrobial drugs, it is possible to create a multifunctional platform that addresses infection control, inflammation modulation, and bone regeneration simultaneously.

Aim:

To develop and characterize heparinized nanohydroxyapatite/collagen biocomposite granules immobilized with anti-inflammatory and/or antimicrobials, and to evaluate their potential for local infection control, inflammation reduction, and bone tissue regeneration. This approach prevents long-term post-infectious conditions arising from osteomyielities.

Objectives:

Preparation and physicochemical characterization of nanohydroxyapatite/collagen granules incorporating anti-inflammatory and/or antimicrobials.

Assessment of anti-inflammatory activity, potentially through cytokine modulation in macrophage or immune cell models.

Investigation of osteoblast compatibility and osteoinductive potential to ensure suitability for bone regeneration.

Establish proof of concept for the use of this multifunctional biocomposite in treating infected bone defects.

Expected Outcomes:

A biocompatible, antibiotic/anti-inflammatory-functionalized nHA/collagen granule system with confirmed antimicrobial and anti-inflammatory activity, to be used particularly in difficult-to-treat infections.

Evidence of osteoblast compatibility and potential to support new bone formation.

Significance:

This work addresses a critical unmet need in orthopedics by proposing a localized, multifunctional strategy to treat bone infections while actively facilitating tissue healing. By integrating infection control, inflammation modulation, and regenerative potential within a single biomaterial platform, the proposed approach aims to reduce reliance on systemic therapies and repeated surgical interventions, thereby improving patient outcomes in bone-related pathologies. In alignment with the broader aim of advancing research on the prevention, diagnosis, and management of post-infection long-term conditions, this strategy contributes to mitigating chronic complications associated with bone infections and supports more effective, durable recovery pathways.

Keywords:

Bone Infection, Osteomyelitis, Nanohydroxyapatite, Collagen, Biocomposite, Antimicrobial, Anti-inflammatory, Bone Regeneration, Biomaterials.